Until now, extensive research exploring the correlations between SLE and a wide spectrum of inflammation-related cytokines has been published—for example, the meta-analyses had reported that VEGF, IL-18, and IL-17 were elevated in patients with SLE than in healthy participants, and they could even serve as indicator of disease activity and severity (24–26). This evidence concerns the gene VEGFA and systemic lupus erythematosus.